Pharma Focus America

News

Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area

Avenacy Introduces Palonosetron Hydrochloride Injection, USP to the U.S. Market

Tuesday, July 23, 2024

Avenacy a specialty pharmaceutical company dedicated to critical injectable medications has introduced Palonosetron Hydrochloride Injection USP in the US This new product serves as a generic version of Aloxi and has received approval from the US Food...

Immutep Receives FDA Endorsement for Phase III Clinical Trial Strategy in Non-Small Cell Lung Cancer

Monday, July 22, 2024

Immutep Limited a biotechnology firm specializing in LAG immunotherapies for cancer and autoimmune diseases has announced that it has received favorable feedback from the US Food and Drug Administration

Antheia Receives New Funding to Expand Domestic Manufacturing of Essential Pharmaceutical Ingredients

Saturday, July 20, 2024

Antheia a company focused on revolutionizing essential medicine supply chains has announced the acquisition of million in new funding This includes a million nondilutive grant from the Biopharmaceutical

ACROBiosystems Introduces New GMP Brand, Resilient Supply, at ISSCR to Enhance Cell and Gene Therapy Development

Friday, July 19, 2024

At the recent International Society for Stem Cell Research Annual Meeting in Hamburg ACROBiosystems introduced its new GMPcentered brand Resilient Supply aimed at accelerating the advancement of cell

Parker Institute Invests Additional $125 Million in Ambitious Cancer Cure Initiative

Friday, July 19, 2024

The Parker Institute for Cancer Immunotherapy has secured a groundbreaking million investment the largest since its inception in This substantial funding boost is set to expand PICIs research

SOTIO and Biocytogen Announce Collaboration to Expand ADC Development with Multi-Target Antibody Agreement

Thursday, July 18, 2024

SOTIO Biotech a clinicalstage biopharmaceutical company under PPF Group and Biocytogen a global biotechnology firm listed on the Hong Kong Stock Exchange have entered into a research collaboration

Biotheryx Commences Phase 1 Clinical Trial of BTX-9341, a Dual Bifunctional CDK4/6 Degrader, for HR+/HER2- Breast Cancer, Including Monotherapy and Combination with Fulvestrant

Thursday, July 18, 2024

Biotheryx Inc a biopharmaceutical company focused on discovering and developing a new class of protein degraders has started a Phase clinical trial for BTX This investigational drug targets cyclindependent kinase

SPI Pharma and Inimmune Corp. Partner to Create Innovative Vaccine Adjuvant Systems

Wednesday, July 17, 2024

SPI Pharma Inc and Inimmune Corp have entered into a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development This partnership

DiscGenics Receives FDA Approval for Phase III Clinical Trial of Injectable Cell Therapy for Lumbar Degenerative Disc Disease

Wednesday, July 17, 2024

DiscGenics Inc a biopharmaceutical company specializing in cellbased regenerative therapies for musculoskeletal degeneration has gained FDA acceptance for its Phase III clinical protocols and Chemistry

AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Reach Milestone in Advancing Biomarkers for Alzheimer’s Disease and Neurodegeneration

Tuesday, July 16, 2024

Fujirebio Holdings Inc and its subsidiary Fujirebio Diagnostics Inc have announced a significant achievement in their strategic partnership with AriBio Co Ltd This collaboration focuses on advancing

Thermo Fisher Scientific - mRNA ServicesFuture Labs Live USA 2024World Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024